Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice-Reference-Cited by-同舟云学术

Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice

Published:2018-11-17 Issue:4 Volume:126 Page:320-325
ISSN:1381-3455
Container-title:Archives of Physiology and Biochemistry
language:en
Short-container-title:Archives of Physiology and Biochemistry

Author:

Ennequin Gaël¹²,Caillaud Kevin¹,Chavanelle Vivien¹,Teixeira Allison¹,Etienne Monique¹,Li Xinyan³,Boisseau Nathalie¹,Sirvent Pascal¹

Affiliation:

1. Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont-Ferrand, France;

2. PEPITE EA4267, and Exercise Performance Health Innovation Platform Univ. Bourgogne Franche-Comté, Besançon, France;

3. Zensun Sci & Tech Ltd, Shanghai, China

Publisher

Informa UK Limited

Subject

Physiology (medical),Physiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13813455.2018.1534243

Reference25 articles.

1. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice

2. Introduction: Molecular Control of Development

3. Neuregulin 1 improves glucose tolerance in adult and old rats

4. Neuregulins and their receptors

5. Hepatic Expression of ErbB3 Is Repressed by Insulin in a Pathway Sensitive to PI-3 Kinase Inhibitors*

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuregulin-1β increases glucose uptake and promotes GLUT4 translocation in palmitate-treated C2C12 myotubes by activating PI3K/AKT signaling pathway;Frontiers in Pharmacology;2023-01-10

2. Decreased expression of ErbB2 on left ventricular epicardial cells in patients with diabetes mellitus;Cellular Signalling;2022-08

3. Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study;JMIR Bioinformatics and Biotechnology;2022-02-23

4. Relationship Between Hepatic Gene Expression, Intestinal Microbiota, and Inferred Functional Metagenomic Analysis in NAFLD;Clinical and Translational Gastroenterology;2022-02-10

5. Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification;Endocrine Reviews;2022-01-13